Ten Things Worth Knowing About Semaglutide

Semaglutide gets talked about everywhere and explained well almost nowhere. Here are ten things we think are worth understanding before you start, from Melissa Kolowitz, PA-C, at Aetheria Aesthetics & Wellness™ in Pittsburgh. This is educational, not medical advice; your own plan belongs in a conversation with a provider who knows your history.

1. It is a copy of a hormone you already make

Semaglutide is a synthetic version of GLP-1, a hormone your gut releases when you eat. GLP-1 prompts insulin, slows the stomach, and eases appetite. Semaglutide simply amplifies those same signals, which is why it helps with both blood sugar and weight (FDA).

2. Once a week is by design, not convenience

Natural GLP-1 breaks down in minutes. Semaglutide is built to resist that breakdown, giving it a half-life of about a week, which is what makes once-weekly dosing possible. Fewer doses tends to mean people stay with treatment (Wilding et al., NEJM, 2021).

3. Ozempic, Wegovy, and Rybelsus are the same molecule

They are all semaglutide. Ozempic is approved for type 2 diabetes, Wegovy at higher doses for weight management, and Rybelsus is the oral tablet. The brand names cause a lot of confusion; the active medication does not change (FDA).

4. The heart data is part of why clinicians take it seriously

Beyond glucose and weight, semaglutide has shown cardiovascular benefit. In the SUSTAIN-6 trial, it reduced major cardiovascular events such as heart attack and stroke by about 26 percent in adults with type 2 diabetes (Marso et al., SUSTAIN-6, NEJM, 2016). That is a meaningful reason it is more than a weight medication.

5. The weight effect is real, and it is dose-dependent

At the full maintenance dose studied for obesity, adults lost about 15 percent of body weight over 68 weeks, among the larger averages reported for a weight medication (Wilding et al., NEJM, 2021). The response builds as the dose steps up, which is why we titrate patiently rather than rushing to the top.

6. It works partly in the brain

Semaglutide reaches appetite centers in the hypothalamus and turns down hunger signals, which is why the effect feels different from willpower (NIH). It is addressing the biology of appetite, not your discipline.

7. The side effects are mostly digestive and mostly temporary

Nausea, diarrhea, and constipation are the common ones, and they cluster around dose increases before easing with time. Careful titration and simple diet adjustments are what keep them manageable (Cleveland Clinic). This is a large part of why supervised dosing matters.

8. The “other uses” are research, not prescriptions

Semaglutide is being studied for conditions like fatty liver disease, PCOS, and even neurologic disease. That research is genuinely interesting, but none of it is an approved use, and we do not prescribe GLP-1 medication for those purposes (JAMA). Be cautious of anyone marketing it that way.

9. There is an oral option, with trade-offs

Rybelsus is a daily tablet for diabetes, useful for people who prefer not to inject, though it requires strict timing on an empty stomach (FDA). Which form fits is a conversation, not a default.

10. The medication is a tool, not the whole plan

Semaglutide does the most when it sits inside real nutrition, activity, and follow-up (American Diabetes Association). In this practice it is one part of a plan, supervised in person, with the same standard we hold everything to: no shortcuts, and an honest answer if it is not right for you.

Sources

• FDA: about Ozempic (semaglutide)
• Wilding et al., STEP 1: once-weekly semaglutide in adults with overweight or obesity, NEJM 2021
• Marso et al., SUSTAIN-6: semaglutide and cardiovascular outcomes, NEJM 2016
• Cleveland Clinic: semaglutide overview
• American Diabetes Association: Standards of Care in Diabetes

If you are weighing whether semaglutide fits, our medical weight loss program is supervised in person by Melissa Kolowitz, PA-C. For the full picture, read our practical guide to GLP-1 therapy, or book a clinical assessment.

This article is educational and does not constitute medical advice. Individual results vary. All treatment decisions are made with a licensed provider.